Replies to post #112660 on Avid Bioservices Inc (CDMO)

[volgoat]

The subgroup data reported at AACR in early April or t ASCO in late May should be very interesting.



Let's hope for some CR's in there.....

[biopharm]

good point FF!

...the Company emphasized in the opening paragraph of today's PR that "Peregrine plans to report additional data from the trial, including updated subgroup analysis and safety data, at an upcoming scientific meeting.

The subgroup data reported at AACR in early April or ASCO in late May should be very interesting.

Peregrine is not about to walk into a scientific meeting with the same exact information that was released today. Save the best for last....the best and more relevant "subgroup analysis" and "safety data" will be the highlight for the scientific community.

GLTA!